Edition:
United Kingdom

Neptune Technologies & Bioressources Inc (NEPT.OQ)

NEPT.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
23 Feb 2018
Change (% chg)

$0.01 (+0.36%)
Prev Close
$2.76
Open
$2.74
Day's High
$2.88
Day's Low
$2.69
Volume
122,163
Avg. Vol
156,325
52-wk High
$3.58
52-wk Low
$0.70

Chart for

About

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Neptune Technologies & Bioressources Q3 ‍Net Income $1.3 Mln Vs $9.4 Mln

Feb 14 Neptune Technologies & Bioressources Inc :

14 Feb 2018

BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION Source text for Eikon: Further company coverage:

12 Feb 2018

BRIEF-Neptune And Tetra Bio-Pharma Sign Co-Development Agreement

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION

12 Feb 2018

BRIEF-Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​

Nov 27 Neptune Technologies & Bioressources Inc :

27 Nov 2017

BRIEF-Neptune Q2 revenue C$6.8 million versus C$11.6 million

* Neptune Technologies & Bioressources Inc - ‍gain of $23.9 million realized from sale of Krill Oil business​

14 Nov 2017

Earnings vs. Estimates